Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 784 participants.
Also called NCT04242134
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 784 participants
- Registry
-
NCT04242134
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04242134. Randomized; single masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2024-06-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
- Acronym
- DCB-BIF
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Drug-coating balloon
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
Record details
- Record id
cardio:ct-nct04242134- Content hash
33db7bf37e1188548f7d799d725b333ae5d9ba9aac4b0793c2fff886bbf990e9